2024-12-182025-12-312025-12-31false16142224VITAL BUILD HMO LTD2026-09-07falseiso4217:GBPxbrli:pure161422242024-12-17161422242025-12-31161422242024-12-182025-12-31161422242024-12-16161422242024-12-17161422242024-12-172024-12-1716142224bus:SmallEntities2024-12-182025-12-3116142224bus:AuditExempt-NoAccountantsReport2024-12-182025-12-3116142224bus:FullAccounts2024-12-182025-12-3116142224bus:PrivateLimitedCompanyLtd2024-12-182025-12-3116142224core:WithinOneYear2025-12-3116142224core:AfterOneYear2025-12-3116142224core:WithinOneYear2024-12-1716142224core:AfterOneYear2024-12-1716142224core:ShareCapital2025-12-3116142224core:SharePremium2025-12-3116142224core:RevaluationReserve2025-12-3116142224core:OtherReservesSubtotal2025-12-3116142224core:RetainedEarningsAccumulatedLosses2025-12-3116142224core:ShareCapital2024-12-1716142224core:SharePremium2024-12-1716142224core:RevaluationReserve2024-12-1716142224core:OtherReservesSubtotal2024-12-1716142224core:RetainedEarningsAccumulatedLosses2024-12-1716142224core:LandBuildings2025-12-3116142224core:PlantMachinery2025-12-3116142224core:Vehicles2025-12-3116142224core:FurnitureFittings2025-12-3116142224core:OfficeEquipment2025-12-3116142224core:NetGoodwill2025-12-3116142224core:IntangibleAssetsOtherThanGoodwill2025-12-3116142224core:ListedExchangeTraded2025-12-3116142224core:UnlistedNon-exchangeTraded2025-12-3116142224core:LandBuildings2024-12-1716142224core:PlantMachinery2024-12-1716142224core:Vehicles2024-12-1716142224core:FurnitureFittings2024-12-1716142224core:OfficeEquipment2024-12-1716142224core:NetGoodwill2024-12-1716142224core:IntangibleAssetsOtherThanGoodwill2024-12-1716142224core:ListedExchangeTraded2024-12-1716142224core:UnlistedNon-exchangeTraded2024-12-1716142224core:LandBuildings2024-12-182025-12-3116142224core:PlantMachinery2024-12-182025-12-3116142224core:Vehicles2024-12-182025-12-3116142224core:FurnitureFittings2024-12-182025-12-3116142224core:OfficeEquipment2024-12-182025-12-3116142224core:NetGoodwill2024-12-182025-12-3116142224core:IntangibleAssetsOtherThanGoodwill2024-12-182025-12-3116142224core:ListedExchangeTraded2024-12-182025-12-3116142224core:UnlistedNon-exchangeTraded2024-12-182025-12-3116142224core:MoreThanFiveYears2024-12-182025-12-3116142224core:Non-currentFinancialInstruments2025-12-3116142224core:Non-currentFinancialInstruments2024-12-1716142224dpl:CostSales2024-12-182025-12-3116142224dpl:DistributionCosts2024-12-182025-12-3116142224core:LandBuildings2024-12-182025-12-3116142224core:PlantMachinery2024-12-182025-12-3116142224core:Vehicles2024-12-182025-12-3116142224core:FurnitureFittings2024-12-182025-12-3116142224core:OfficeEquipment2024-12-182025-12-3116142224dpl:AdministrativeExpenses2024-12-182025-12-3116142224core:NetGoodwill2024-12-182025-12-3116142224core:IntangibleAssetsOtherThanGoodwill2024-12-182025-12-3116142224dpl:GroupUndertakings2024-12-182025-12-3116142224dpl:ParticipatingInterests2024-12-182025-12-3116142224dpl:GroupUndertakingscore:ListedExchangeTraded2024-12-182025-12-3116142224core:ListedExchangeTraded2024-12-182025-12-3116142224dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-12-182025-12-3116142224core:UnlistedNon-exchangeTraded2024-12-182025-12-3116142224dpl:CostSales2024-12-172024-12-1716142224dpl:DistributionCosts2024-12-172024-12-1716142224core:LandBuildings2024-12-172024-12-1716142224core:PlantMachinery2024-12-172024-12-1716142224core:Vehicles2024-12-172024-12-1716142224core:FurnitureFittings2024-12-172024-12-1716142224core:OfficeEquipment2024-12-172024-12-1716142224dpl:AdministrativeExpenses2024-12-172024-12-1716142224core:NetGoodwill2024-12-172024-12-1716142224core:IntangibleAssetsOtherThanGoodwill2024-12-172024-12-1716142224dpl:GroupUndertakings2024-12-172024-12-1716142224dpl:ParticipatingInterests2024-12-172024-12-1716142224dpl:GroupUndertakingscore:ListedExchangeTraded2024-12-172024-12-1716142224core:ListedExchangeTraded2024-12-172024-12-1716142224dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-12-172024-12-1716142224core:UnlistedNon-exchangeTraded2024-12-172024-12-1716142224core:NetGoodwill2025-12-3116142224core:IntangibleAssetsOtherThanGoodwill2025-12-3116142224core:LandBuildings2025-12-3116142224core:PlantMachinery2025-12-3116142224core:Vehicles2025-12-3116142224core:FurnitureFittings2025-12-3116142224core:OfficeEquipment2025-12-3116142224core:AfterOneYear2025-12-3116142224core:WithinOneYear2025-12-3116142224core:ListedExchangeTraded2025-12-3116142224core:UnlistedNon-exchangeTraded2025-12-3116142224core:ShareCapital2025-12-3116142224core:SharePremium2025-12-3116142224core:RevaluationReserve2025-12-3116142224core:OtherReservesSubtotal2025-12-3116142224core:RetainedEarningsAccumulatedLosses2025-12-3116142224core:NetGoodwill2024-12-1716142224core:IntangibleAssetsOtherThanGoodwill2024-12-1716142224core:LandBuildings2024-12-1716142224core:PlantMachinery2024-12-1716142224core:Vehicles2024-12-1716142224core:FurnitureFittings2024-12-1716142224core:OfficeEquipment2024-12-1716142224core:AfterOneYear2024-12-1716142224core:WithinOneYear2024-12-1716142224core:ListedExchangeTraded2024-12-1716142224core:UnlistedNon-exchangeTraded2024-12-1716142224core:ShareCapital2024-12-1716142224core:SharePremium2024-12-1716142224core:RevaluationReserve2024-12-1716142224core:OtherReservesSubtotal2024-12-1716142224core:RetainedEarningsAccumulatedLosses2024-12-1716142224core:NetGoodwill2024-12-1616142224core:IntangibleAssetsOtherThanGoodwill2024-12-1616142224core:LandBuildings2024-12-1616142224core:PlantMachinery2024-12-1616142224core:Vehicles2024-12-1616142224core:FurnitureFittings2024-12-1616142224core:OfficeEquipment2024-12-1616142224core:AfterOneYear2024-12-1616142224core:WithinOneYear2024-12-1616142224core:ListedExchangeTraded2024-12-1616142224core:UnlistedNon-exchangeTraded2024-12-1616142224core:ShareCapital2024-12-1616142224core:SharePremium2024-12-1616142224core:RevaluationReserve2024-12-1616142224core:OtherReservesSubtotal2024-12-1616142224core:RetainedEarningsAccumulatedLosses2024-12-1616142224core:AfterOneYear2024-12-182025-12-3116142224core:WithinOneYear2024-12-182025-12-3116142224core:Non-currentFinancialInstrumentscore:CostValuation2024-12-182025-12-3116142224core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-182025-12-3116142224core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-182025-12-3116142224core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-182025-12-3116142224core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-182025-12-3116142224core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-182025-12-3116142224core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-182025-12-3116142224core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-182025-12-3116142224core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-182025-12-3116142224core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3116142224core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3116142224core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3116142224core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3116142224core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3116142224core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3116142224core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3116142224core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3116142224core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3116142224core:Non-currentFinancialInstrumentscore:CostValuation2024-12-1716142224core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-1716142224core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-1716142224core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-1716142224core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-1716142224core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-1716142224core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-1716142224core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-1716142224core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-1716142224bus:Director12024-12-182025-12-3116142224bus:Director22024-12-182025-12-3116142224bus:Director32024-12-182025-12-31

VITAL BUILD HMO LTD

Registered Number
16142224
(England and Wales)

Unaudited Financial Statements for the Period ended
31 December 2025

VITAL BUILD HMO LTD
Company Information
for the period from 18 December 2024 to 31 December 2025

Directors

BETTS, Alex Michael
JORDAN, Michael James
YANYSHYN, Oksana

Registered Address

C/O Roca Accountants Limited, Floor 4 Centenary House
1 Centenary Way
Manchester
M50 1RF

Registered Number

16142224 (England and Wales)
VITAL BUILD HMO LTD
Balance Sheet as at
31 December 2025

Notes

2025

£

£

Fixed assets
Investment property3434,985
434,985
Current assets
Debtors541
Cash at bank and on hand1,034
1,575
Creditors amounts falling due within one year4(173,094)
Net current assets (liabilities)(171,519)
Total assets less current liabilities263,466
Creditors amounts falling due after one year5(265,774)
Net assets(2,308)
Capital and reserves
Called up share capital99
Profit and loss account(2,407)
Shareholders' funds(2,308)
The financial statements were approved and authorised for issue by the Board of Directors on 7 September 2026, and are signed on its behalf by:
YANYSHYN, Oksana
Director
Registered Company No. 16142224
VITAL BUILD HMO LTD
Notes to the Financial Statements
for the period ended 31 December 2025

1.Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Investment property
The investment property is accounted for under FRS 102, Section 16 Investment Property. Investment property is remeasured to fair value at each balance sheet date with fair value gains and losses being reported in profit or loss. Investment properties are valued using RICS open market valuation on a freehold basis.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

2025
Average number of employees during the year3
3.Investment property

£
Additions434,985
At 31 December 25434,985
4.Creditors: amounts due within one year

2025

£
Other creditors171,594
Accrued liabilities and deferred income1,500
Total173,094
5.Creditors: amounts due after one year

2025

£
Bank borrowings and overdrafts265,774
Total265,774